PT  - JOURNAL ARTICLE
AU  - Powers, Jenny
ED  - Kay, Jonathan
TI  - The Role of Biosimilar and Orphan Drugs in Treating Patients with Rheumatologic Disease
DP  - 2014 Aug 01
TA  - MD Conference Express
PG  - 6--8
VI  - 14
IP  - 17
4099  - http://mdc.sagepub.com/content/14/17/6.short
4100  - http://mdc.sagepub.com/content/14/17/6.full
AB  - Biosimilar drugs may offer affordable targeted therapies to patients across a spectrum of rheumatologic, oncologic, and gastrointestinal diseases, but they pose unique clinical trial design and licensing issues. Governments provide incentives for developing orphan drugs that would not otherwise be cost-effective to manufacture, allowing for the possibility of effective treatment options for rare diseases, including many rheumatologic conditions.